As a child growing up in Bolivia, Emiliana RodrĂguez remembers one night that would shape her understanding of illness forever. She was watching neighborhood friends play soccer under dim streetlights when one boy suddenly collapsed and died. At the time, she didn’t understand what had happened. Adults whispered about Chagas disease—a parasitic infection spread by nocturnal insects called triatomine or “kissing” bugs.
Chagas disease, caused by the parasite Trypanosoma cruzi, affects an estimated 6 to 7 million people worldwide, mostly in Latin America. Around 12,000 people die annually from its complications. Despite being preventable and treatable in early stages, it remains a neglected tropical disease.
RodrĂguez eventually moved to Barcelona, Spain, but the disease followed her in an unexpected way. Eight years ago, while pregnant with her first child, she learned she was infected. Memories of her childhood friend’s sudden death flooded back, and fear gripped her. Chagas can be transmitted from mother to child during pregnancy, but early detection allowed her to receive treatment that prevented transmission. Her daughter was born healthy. RodrĂguez’s story illustrates a critical truth: early screening can save lives.
In Mexico, Elvira Idalia Hernández Cuevas discovered the disease differently. Her 18-year-old daughter, donating blood near Veracruz, tested positive for T. cruzi. Hernández, unfamiliar with the disease, found alarming descriptions online calling it a “silent killer.” Many carriers show no symptoms for years, sometimes decades, before severe complications develop.
The parasite spreads primarily through contact with infected triatomine bug feces. After biting, these insects may defecate near the wound, allowing the parasite to enter the body through scratches or mucous membranes. It can also spread through blood transfusions, organ transplants, contaminated food, lab accidents, and from mother to child. Migration and travel have led to cases in the U.S., Europe, and Asia, though it remains largely concentrated in Latin America.
Chagas disease was first described in 1909 by Brazilian physician Carlos Chagas, who identified the parasite, vector, reservoirs, and clinical effects in one study—a remarkable achievement. Yet over a century later, millions remain affected, often in low-income areas where housing allows triatomine bugs to hide. Limited awareness among healthcare providers and social factors have kept diagnosis and treatment low.
Only about 10% of those infected receive a formal diagnosis. Many countries lack routine screening, particularly for pregnant women or blood donors, leaving individuals unaware until complications arise. Chronic infection can lead to heart disease, gastrointestinal issues, and even death. The WHO and CDC emphasize prevention, early detection, and treatment as crucial strategies.
Treatment options are limited to benznidazole and nifurtimox, effective primarily in the acute phase or in children. Adults with chronic infection may see reduced parasite levels, but cure is not guaranteed. Side effects can include rash, nausea, and neuropathy. RodrĂguez experienced some of these challenges but completed therapy and continues regular monitoring. Research into safer, more effective treatments is ongoing through organizations like the Drugs for Neglected Diseases initiative (DNDi).
Awareness efforts include World Chagas Disease Day on April 14, honoring Chagas’ discovery. Global initiatives in Europe and Latin America aim to increase screening, particularly among migrant communities, and prevent mother-to-child transmission. However, experts caution that elimination targets for 2030 will require significant investment in healthcare infrastructure and education.
Prevention focuses on reducing contact with triatomine bugs. Recommended measures include sealing cracks in walls and roofs, installing screens, keeping pets indoors at night, and removing debris near homes. If a bug is found, it should be captured safely for identification rather than crushed, reducing the risk of infection.
For RodrĂguez, Chagas disease remains a part of her life story. She advocates for awareness, testing, and treatment, breaking the silence around a disease often hidden from public attention. Hernández also works to amplify patient voices globally, highlighting the social as well as medical challenges.
Chagas disease is silent, dangerous, and underrecognized. Yet with education, early detection, and global cooperation, its impact can be minimized. The tragedy that shaped RodrĂguez’s childhood echoes worldwide, reminding us that awareness and action are the first steps in controlling this neglected disease. Through vigilance and advocacy, the silent threat can be confronted—and lives saved.